Guidelines were provided for basal cell carcinoma and cutaneous squamous cell carcinoma.
Patients with atopic dermatitis may have a greater risk of developing squamous cell carcinoma.
Oxybenzone, found in sunscreens and other products, has harmful dermatological and environmental effects.
The USPSTF has released updated recommendations on skin cancer counseling and self-examination for adults with fair skin.
Primary care screening can help patients avoid the need for more aggressive therapy and potentially save lives.
More cases of skin cancer are diagnosed each year than of breast, prostate, lung, and colon cancers combined, and early detection is critical.
Learn about nevoid basal cell carcinoma syndrome, including how to diagnose and manage this genetic condition.
A new blood test assesses levels of circulating tumor DNA (ctDNA) in patients with unresectable stage IIIC/IV melanoma.
The USPTF has determined that there is insufficient evidence for the harms and benefits of visual skin cancer screening.
Performing skin checks during other procedures can identify abnormalities that would otherwise be overlooked.
A non-invasive laser test can accurately identify melanoma with 100% accuracy.
Many moles increases melanoma risk, but fewer moles are linked to more aggressive forms of melanoma.
Clinicians should warn patients about the dangers of sunburn and discourage this new trend.
Fun at the beach exposes children and adults to a number of hazards—some avoidable, such as sunburn, and some less so.
Men who took erectile dysfunction medication had increased risk for melanoma, but it is probably due to lifestyle factors.
The prevalence of itch was 36.9%, and the prevalence of pain was 28.2% across all skin cancer, but these symptoms were mainly absent in melanomas
The start of the "sun-worshipping season" is a good time to review the primary-care basics of basal cell and squamous cell carcinomas.
Meta-analysis based on cohort studies finds link between IBD and increased risk for developing melanoma.
Prevalence increases with age for high-school students, peaking in the 18 to 21 age group and decreasing with age among 18- to 34-year-olds.
Doctors discourage getting tattoos over pre-existing lesions after discovering a cancerous mole on a patient during tattoo removal.
Melanoma risk increases with each additional session of sunbed use per year, and for those whose first use was before age 35 years.
Patients may already know they should use a SPF 30 sunscreen, but are they applying it properly?
Two patients present with asymptomatic red lesions -- a 60-year-old man, whose lesion was present for five years before beginning to bleed, and a 27-year-old man whose lesion doubled in size during a two year period. Can you differentiate between the two?
Counseling moderately increases the use of sun-protective behaviors in 10- to 24-year-old patients who are at high risk for skin cancer.
Teen girls will come up with 100 reasons to use tanning beds. We as health-care providers need to give parents one really big reason to say no.
More young adults, particularly women, are being diagnosed with cutaneous melanoma, but overall and disease-specific survival is improving.
The FDA has approved vismodegib as the first treatment for basal cell carcinoma, the most common form of skin cancer.
Highest risk seen for patients with previous diagnosis of cutaneous melanoma
MelaFind, a computer-assisted melanoma-detecting device developed by MELA Sciences, has received FDA pre-market approval (PMA) for use on atypical cutaneous pigmented lesions.
Two patients present with newly developed brown papules. The first patient, a 45-year-old man, presented with a new mole that continues to grow and is associated with occasional pruritus and bleeding. The second patient, a 47-year-old man, presented with a 6-month history of a brown, growing "mole." Can you differentiate between the two?